29
Participants
Start Date
April 21, 2023
Primary Completion Date
November 29, 2023
Study Completion Date
November 29, 2023
Long-Acting Beta Agonist
The Investigator will prescribe standard of care LABA to eligible study participants. Participants will self-administer LABA once or twice daily at the maximum feasible standard of care dosage, per the time points specified in the study Schedule of Assessments. LABA should be taken within 1 to 3 hours prior to morning and evening at-home mobile Spirometry testing.
American Health Research, Charlotte
Spartanburg Medical Research, Spartanburg
Clinical Research of Rock Hill, Rock Hill
AllerVie Research Clinic, Columbus
AllerVie Research Clinic, Birmingham
The Asthma & Allergy Center, PC, Bellevue
South Texas Allergy & Asthma Medical Professionals Research, San Antonio
El Paso Pulmonary Association, El Paso
Northeast Medical Research Associates, Inc., North Dartmouth
Lead Sponsor
Koneksa Health
INDUSTRY